Hosted on MSN7mon
HUGE Stock Earnings: FSD Pharma Misses EPS for Q2 2024
FSD Pharma (NASDAQ:HUGE) just reported results for the second quarter of 2024. FSD Pharma reported earnings per share of -8 cents. This was below the analyst estimate for EPS of -6 cents.
CNN6mon
Quantum Biopharma Ltd. Subordinate Voting Shares Class B
Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development ... of the company's three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS. The Strategic ...